YESTAR HEALTH (02393) announced that on October 10, 2025, the company received a notice from its non-executive director He Zhenfa, stating that the loan had been fully repaid to the lender on the same day. The lender and receiver will proceed with the procedures to release the pledged shares and execute relevant documents (release documents). Upon the lender's submission of the relevant release documents for filing, all pledged shares will be released, and the company will have no other shares subject to pledge restrictions.